Brad Knott sold Oramed Pharmaceuticals Inc (NASDAQ: ORMP)
Brad Knott sold ORMP · disclosed February 25, 2025
Brad Knott, a NC House member representing District 13, sold $15,001 - $50,000 of Oramed Pharmaceuticals Inc (ORMP) on January 10, 2025. Filings associated with Brad Knott disclosed 0 other ORMP transactions in the 12 months before this trade. Shares of ORMP have risen 124.9% since the first observed purchase on January 10, 2025. The filing was publicly disclosed on February 25, 2025; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Brad Knott's complete filing history, visit Brad Knott's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- ORMP carries a Risk Score of 76 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Brad Knott sold ORMP in the amount range of $15,001 - $50,000 on January 10, 2025, filed under the STOCK Act.
- The filing lists Self as the transaction owner and was disclosed 46 days after the trade.
- The asset description in the filing reads 'Oramed Pharmaceuticals Inc. - Common Stock (ORMP) [ST].'
- Filings associated with Brad Knott disclosed 0 other ORMP transactions in the 12 months before this trade.
- Shares of ORMP have risen 124.9% since the first observed purchase on January 10, 2025.
- ORMP carried a Q Score of 95 in its equity peer group as of September 4, 2026.
- ORMP carried a Squeeze Score of 28 as of September 8, 2026.
Did Brad Knott buy or sell ORMP?
The Periodic Transaction Report covers a single sale involving ORMP on January 10, 2025. The filed amount range is $15,001 - $50,000. The asset description reads 'Oramed Pharmaceuticals Inc. - Common Stock (ORMP) [ST]', as submitted by the filer. The report was submitted on February 25, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Brad Knott (House) | Sell | ORMP | $15,001 - $50,000 | January 10, 2025 | February 25, 2025 |
What other ORMP trades has Brad Knott disclosed in the past 12 months?
Filings associated with Brad Knott disclosed 0 other ORMP transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other ORMP transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a sale involving ORMP by Brad Knott in the amount range of $15,001 - $50,000, with Self listed as the owner. It does not establish Brad Knott's total holdings in ORMP, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Oramed Pharmaceuticals Inc. - Common Stock (ORMP) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Brad Knott's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Brad Knott disclosed 0 other ORMP transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded ORMP?
Quantellect's current database lists these recent ORMP disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has Brad Knott's disclosed trading performed?
Brad Knott holds a Quantellect Q Score of 27 (mixed), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #57 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Brad Knott ORMP trades
Frequently asked questions
Did Brad Knott buy or sell ORMP?
According to the disclosure, Brad Knott sold ORMP on January 10, 2025.
What amount was reported for the ORMP transaction?
The disclosure reports $15,001 - $50,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated January 10, 2025, and it was disclosed on February 25, 2025.
Where can I see Brad Knott's other congressional trades?
Quantellect lists Brad Knott's complete disclosed trade history on the member profile. Brad Knott's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.